BRC Biotechnology has built comprehensive development and validation capabilities across molecular, microbial, viral, cell, and animal technology platforms, in strict compliance with global pharmacopoeias, regulations, and industry quality standards. Adhering to these rigorous industry quality standards, BRC Biotechnology has achieved a series of prestigious certifications, including the EU GMP Qualified Person (QP) compliance statement, the United States FDA Facility Establishment Identifier (FEI), ISO 9001: 2015 certification, Biosafety Level 2 (BSL-2) accreditation, China Metrology Accreditation (CMA), China National Accreditation Service for Conformity Assessment (CNAS), and more. With years of biosafety testing experience, deep regulatory expertise, and strong innovation capabilities, BRC Biotechnology has delivered high-quality, compliance-driven biosafety testing services to dozens of domestic and international biotech companies. Our services have been instrumental in supporting their products through the regulatory approval processes with the National Medical Products Administration (NMPA), the European Medicines Agency (EMA), the U.S. Food and Drug Administration (FDA), and other regulatory bodies for Investigational New Drug (IND) and Biologics License Application (BLA) submissions. As your reliable biotech-service partner on the path to success, we are committed to delivering world-class biosafety services to ensure your products meet the highest standards of quality and safety.